New publications from BPSA and PDA highlight best practices for particulate control, quality agreements, and implementation strategies.
New publications from BPSA and PDA highlight best practices for particulate control, quality agreements, and implementation strategies.
Download this article
from BioPharm International’s 2014 Secure Single-Use Systems eBook.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.